All Press Releases for September 12, 2023

Lesley Anne Mathews, M.Ed., PhD, Recognized by Marquis Who's Who for Leadership in Cancer Research and Education

Lesley Anne Mathews is an award-winning scientist and researcher

Dr. Mathews boasts over 23 years of critical laboratory experience working with microorganisms, vaccine production, cancer biology and therapeutics, and robotics.

    GROTON, MA, September 12, 2023 /24-7PressRelease/ -- Lesley Anne Mathews, M.Ed., Ph.D., has been included in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Dr. Mathews boasts over 23 years of critical laboratory experience working with microorganisms, vaccine production, cancer biology and therapeutics, and robotics. Since 2023, Dr. Mathews has excelled as the scientific director of the Society for Laboratory Automation and Screening, a non-profit organization dedicated to teaching automation robotics and life sciences. With a focus on relevant outreach and education, she provides strategic leadership to facilitate and coordinate the scientific content and delivery of the company's educational sessions, and she assembles the appropriate personnel for classes, courses and webinars. Dr. Mathews also holds oversight and location scouting for the SLAS trade shows—the organization's most prominent events—and manages two affiliated peer-reviewed journals, SLAS Discovery and SLAS Technology. Additionally, Dr. Mathews is the acting scientific liaison in building and maintaining the organization's relationships with related scientific disciplines, and she travels internationally to accumulate knowledge about other sites and their processes.

A survey of Dr. Mathews' professional pursuits reveals an extensive list of prestigious appointments, including several distinct positions at the Broad Institute of MIT and Harvard. She held the title of coordinator of communications and culture for the Center for the Development of Therapeutics from 2022 to 2023 and served as the associate director of cellular pharmacology from 2020 to 2023. Dr. Mathews also notably acted as a senior group leader for translational pharmacology there between 2020 and 2021.

Other distinct career highlights include an adjunct faculty appointment with the NIH Office of Science Education from 2009 to 2014 and a successful tenure as a research scientist with the National Center for Advancing Translational Sciences between 2010 and 2014. While a valued associate at Novartis, where she served in the role of investigator II, oncology, from 2014 to 2017 and as principal scientist II, oncology and molecular pharmacology, from 2017 to 2020, Dr. Mathews was part of the team that delivered a compound named LXH254 for the potential treatment of melanoma to the clinic and patients; she counts this advancement as one of her most notable achievements thus far.

Dr. Mathews brings impressive academic credentials to each appointment, including a Ph.D. in molecular biology from the University of Massachusetts Amherst; she completed the terminal degree in 2008. She also holds a Bachelor of Arts in biology-chemistry from Clark University, and in 2020, she proudly earned a Master of Science in secondary education and teaching in biology from Lesley University. Notably, between 2008 and 2010, Dr. Mathews was recognized as a postdoctoral research fellow at the National Cancer Institute.

Dr. Mathews was motivated to pursue a role in cancer research after losing her father to the disease. Through diverse channels that include administrative and hands-on functions, as well as extensive online research and exploration, she has earned numerous accolades that define both her academic and professional profiles. She was recognized as a Sallie Rosen Kaplan Postdoctoral Research Fellow by the National Cancer Institute at the National Institutes of Health or NIH in 2008, and she humbly accepted the Kelly Government Solutions Award for Combination Matrix Screening in 2012. Ds. Mathews also received the NIH Directors Award in 2013 for creating a matrix combination screening platform for use in small molecule and siRNA screens and the Diversity and Inclusion Award from Novartis in 2015.

Dr. Mathews is an award-winning researcher and teacher with over 45 publications to her credit; in particular, she avidly contributes to the scholarly conversation surrounding high-throughput screening and drug discovery. She is also an engaging presenter, connecting with audiences at the 2013 and 2015 SLAS conferences and exhibitions and at a TEDx event in 2022. Civic service is also foundational to her legacy, and she was gratified to be named to the board of directors and acknowledged as the mentoring committee co-chair of the Association for Women in Science, Massachusetts chapter, from 2014 through 2016.

Dr. Mathews attributes her record of accomplishment thus far to perseverance and resiliency. Looking toward the future, she aims to pursue an administrative position at an academic institution, moving into the role of chancellor or dean to hold oversight of programs for research and application.

About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Marquis celebrates its 125th anniversary in 2023, and Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® publications may be visited at the official Marquis Who's Who® website at

# # #

Contact Information

-- --
Marquis Who's Who Ventures LLC
Uniondale, NY
Voice: 844-394-6946
E-Mail: Email Us Here
Website: Visit Our Website
Follow Us: